We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NVST:NYSEEnvista Holdings Corporation Analysis

Data as of 2026-08-01 - not real-time

$27.31

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Envista Holdings (NVST) is trading at $27.31, just above its 20‑day SMA (26.72) and comfortably above the 50‑day SMA (25.48), with a bullish MACD crossover and an RSI of 56 indicating modest upside momentum. Technicals point to a bullish trend, while the DCF‑derived fair value of $27.87 suggests roughly 8% upside, aligning with analyst median targets near $30.
Fundamentally, revenue is growing at 14% YoY and margins are solid (gross 55%, operating 10%), but profit margins remain thin (2.4%). Forward EPS of $1.57 versus trailing $0.41 drives the forward P/E down to 17x, a stark improvement over the trailing 66x, though the stock remains expensive relative to the industry average P/E of 29x. The balance sheet shows $1.08B cash offsetting $1.59B debt, leaving modest net leverage, and the company pays no dividend.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD and price above short‑term moving averages
  • DCF upside of ~8% and analyst price targets above current level
  • Upcoming Q2 earnings release could confirm earnings acceleration

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward earnings growth reflected in a forward P/E of 17x
  • Improving operating margins and stable cash flow generation
  • Consensus analyst recommendation of "Buy" with 14 analysts covering the stock

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Moderate leverage and solid cash position support financial stability
  • Exposure to regulatory changes in dental device approvals
  • High beta (≈1.3) and 30‑day volatility (~34%) suggest price swings that merit a cautious stance

Key Metrics & Analysis

Financial Health

Revenue Growth14.40%
Profit Margin2.41%
P/E Ratio66.6
ROE2.21%
ROA3.01%
Debt/Equity51.61
P/B Ratio1.4
Op. Cash Flow$272.1M
Free Cash Flow$216.3M
Industry P/E29.2

Technical Analysis

TrendBullish
RSI56.7
Support$25.22
Resistance$28.84
MA 20$26.72
MA 50$25.48
MA 200$24.33
MACDBullish
VolumeStable
Fear & Greed Index92.88

Valuation

Fair Value$27.87
Target Price$29.43
Upside/Downside7.76%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.30
Volatility34.11%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.